Narayana Hrudayalaya Limited submitted a revised investor presentation for Q1 FY27 (quarter ended June 30, 2026) to BSE Limited and National Stock Exchange of India Limited. The submission was digitally signed by Sridhar S., Group Company Secretary, Legal & Compliance Officer.

Operational Footprint (as of July 1, 2026)

The company operates 55 healthcare facilities with 5,955 operational beds:

  • India: 20 hospitals and heart centers (5,461 beds) + 20 clinics and dialysis centers (0 beds)
  • Cayman Islands: 2 facilities (164 beds)
  • United Kingdom: 13 facilities (330 beds)
  • Total staff: ~20,950 (Clinical: ~12,900, Non-clinical: ~8,050)

Regional breakdown in India:

  • South India: 6 hospitals, 2 heart centers, 14 clinics, 1 diagnostic center, 2,043 hospital beds, 132 heart center beds
  • East India: 7 hospitals, 4 clinics, 1 dialysis center, 2,074 operational beds
  • North India: 3 hospitals, 838 operational beds
  • West India: 2 hospitals, 374 operational beds

Operational Highlights Q1 FY27

  • Narayana Institute of Cardiac Sciences, Bengaluru performed 2,137 cardiac surgeries and 19 Pulse Field Ablation procedures for Atrial Fibrillation since launch in India (June 2026)
  • Narayana Hospital, Gurugram operationalized CUVIS Ortho Robotic System and Thulium Laser System
  • Wide spectrum of robotic surgeries performed including Robotic CBD Exploration, Robot-assisted Hiatus & Ventral Hernia Repair, Robotic Simple Prostatectomy, and Robotic Cytoreductive Surgery

Financial Performance Q1 FY27

  • Consolidated operating revenues: ₹26,836 Mn (+78.0% YoY, +3.5% QoQ)
  • Consolidated EBITDA: ₹5,052 Mn (18.8% margin)
  • Consolidated PAT: ₹2,073 Mn (7.7% margin)
  • Consolidated Total Borrowings less Cash & Bank Balance and Investments: ₹19,671 Mn as on June 30, 2026
  • Net debt to equity ratio: 0.42
  • Foreign currency denominated debt: US $115 Mn and GBP £150 Mn

India Operations Revenue Mix Q1 FY27

Revenue breakdown by patient type (excluding NHIC):

  • Domestic Walk-in patients
  • Insured Patients (insurance-covered, corporate patients including PSU's on hospital tariff)
  • Schemes (CGHS, ESIS, other state government schemes)
  • International patients

India Hospitals Operations Q1 FY27

  • ARPOB: ₹19.2 Mn (vs ₹17.6 Mn in Q1 FY26)
  • EBITDA of India Hospitals: ₹2,901 Mn (21.9% margin)
  • Cost structure: Doctors and Nurses (employee benefits + professional fees), Consumable Expenses, Other Expenses

NH Insurance Business Q1 FY27

  • Gross Written Premium: ₹262 Mn (vs ₹17 Mn in Q1 FY26)
  • Net Written Premium: ₹252 Mn
  • Net Earned Premium: ₹101 Mn
  • Net Incurred Claims: ₹220 Mn
  • Profit After Tax: -₹201 Mn
  • Key Ratios: Expense Ratio/NWP 41%, Claims Ratio/NEP 219%, Combined Operating Ratio 259%, Solvency Ratio 167%

Cayman Islands Operations Q1 FY27

  • EBITDA: US$ -3.7 Mn
  • HCCI consolidated revenue adjustment for inter-company elimination: US$ 2.0 Mn

United Kingdom Operations Q1 FY27

  • Q3 FY26 numbers considered from November 6, 2025 (effective date of acquisition)
  • One-time acquisition costs excluded from EBITDA
  • New center loss for Q1 FY27: GBP 1.1 Mn

Financial Statements

Profit and Loss Statement (₹ Mn)

| Particulars | Q1 FY26 | Q1 FY27 |

| Total Operating Revenue | 15,073 | 26,836 |

| Consumption | 3,058 | 5,143 |

| Doctors Expenses | 2,442 | 3,270 |

| Employee (Excluding Doctors) Expenses | 2,955 | 7,248 |

| Other Admin Expenses | 3,248 | 6,478 |

| Total Expenses | 11,703 | 22,139 |

| Other Income | 238 | 355 |

| EBITDA | 3,607 | 5,052 |

| Depreciation and Amortization | 843 | 1,561 |

| Finance Costs | 452 | 868 |

| Share of (loss)/profit of equity accounted investees | (4) | (19) |

| PBT | 2,308 | 2,604 |

| Tax Expense | 348 | 531 |

| PAT | 1,961 | 2,073 |

| Total Comprehensive Income | 1,972 | 1,940 |

Balance Sheet Items as of June 30, 2026 (₹ Mn)

  • Shareholder Equity: 47,336
  • Total Borrowings: 48,776
  • Lease Liability: 9,711
  • Net Block + CWIP: 48,258 (includes non-cash government grant impact of ₹1,019 Mn, non-cash financial lease impact of ₹176 Mn, and non-cash EPCG license impact of ₹344 Mn)
  • Goodwill: 13,923
  • Right to Use Assets: 8,230
  • Net Receivables: 7,037
  • Current Investments: 8,240
  • Cash and Bank Balance: 19,934

Shareholding Pattern

  • Total Number of Shares: 204,360,804 as on June 30, 2026
  • Major institutional shareholders include: Mirae Asset Management, Parag Parikh Asset Management, Vanguard Index Fund, Franklin Templeton Investment Funds, Nippon Life India Asset Management, Axis Asset Management, Simcah Partners LP, iShares by Blackrock, Unifi Capital, Government Pension Fund Global, DSP Asset Management, Mirae Asset Fund

Disclaimer

The document contains forward-looking statements subject to various risks and uncertainties. The presentation is for general information purposes only and does not constitute an offer or invitation to purchase shares.